|
|
|
|
LEADER |
01000caa a22002652c 4500 |
001 |
NLM361763220 |
003 |
DE-627 |
005 |
20250305054920.0 |
007 |
cr uuu---uuuuu |
008 |
231226s2023 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1016/j.clim.2023.109753
|2 doi
|
028 |
5 |
2 |
|a pubmed25n1205.xml
|
035 |
|
|
|a (DE-627)NLM361763220
|
035 |
|
|
|a (NLM)37678714
|
035 |
|
|
|a (PII)S1521-6616(23)00516-8
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Wang, Ziye
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Tyro3 receptor tyrosine kinase contributes to pathogenic phenotypes of fibroblast-like synoviocytes in rheumatoid arthritis and disturbs immune cell balance in experimental arthritis
|
264 |
|
1 |
|c 2023
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 02.10.2023
|
500 |
|
|
|a Date Revised 02.05.2024
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a Copyright © 2023 Elsevier Inc. All rights reserved.
|
520 |
|
|
|a Rheumatoid arthritis (RA) is a systemic autoimmune disorder characterized by synovitis and joint damage, the underlying causes of which remain unclear. Our prior investigations revealed a notable correlation between the expression of Tyro3 Protein Tyrosine Kinase (Tyro3TK) and the progression of RA. To further elucidate the pathogenic role of Tyro3TK in RA, we analyzed the influence of Tyro3TK on pathogenic phenotypes of RA fibroblast like synoviocyte (FLS) in vitro and compared disease severity, joint damages and immunological parameters of K/BxN serum transfer arthritis (STA) in Tyro3TK-/- deficient mice and wild type controls. Our findings underscored the remarkable effectiveness of Tyro3TK blockade, as evidenced by diminished secretion of inflammatory cytokines and matrix metalloproteinases (MMPs), curtailed migration and invasiveness of RAFLS, and attenuated differentiation of pathogenic helper T cell subsets mediated by RAFLS. Correspondingly, our in vivo investigations illuminated the more favorable outcomes in Tyro3TK-deficient mice, characterized by reduced joint pathology, tempered synovial inflammation, and restored immune cell equilibrium. These data suggested that Tyro3TK might contribute to aggravated autoimmune arthritis and immunological pathology and act as a potential therapeutic target for RA
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a Research Support, Non-U.S. Gov't
|
650 |
|
4 |
|a Fibroblast like synoviocyte
|
650 |
|
4 |
|a K/BxN serum transfer arthritis
|
650 |
|
4 |
|a Rheumatoid arthritis
|
650 |
|
4 |
|a Tyro3TK
|
650 |
|
7 |
|a Protein-Tyrosine Kinases
|2 NLM
|
650 |
|
7 |
|a EC 2.7.10.1
|2 NLM
|
650 |
|
7 |
|a Receptor Protein-Tyrosine Kinases
|2 NLM
|
650 |
|
7 |
|a EC 2.7.10.1
|2 NLM
|
650 |
|
7 |
|a Tyro3 protein, mouse
|2 NLM
|
650 |
|
7 |
|a EC 2.7.10.1
|2 NLM
|
650 |
|
7 |
|a TYRO3 protein, human
|2 NLM
|
650 |
|
7 |
|a EC 2.7.10.1
|2 NLM
|
700 |
1 |
|
|a Zhao, Zhen
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Li, Zhichang
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Xu, Liling
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Li, Hongchao
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Zhu, Huaqun
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Cheng, Gong
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Yao, RanRan
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Pei, Wenwen
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Liang, Ruyu
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Liang, Renge
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Ye, Hua
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Jiang, Shan
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Niu, Haitao
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Sun, Xiaolin
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Su, Yin
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Clinical immunology (Orlando, Fla.)
|d 1999
|g 255(2023) vom: 15. Okt., Seite 109753
|w (DE-627)NLM098196855
|x 1521-7035
|7 nnas
|
773 |
1 |
8 |
|g volume:255
|g year:2023
|g day:15
|g month:10
|g pages:109753
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1016/j.clim.2023.109753
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_11
|
912 |
|
|
|a GBV_ILN_24
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 255
|j 2023
|b 15
|c 10
|h 109753
|